We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+8.53%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$9.21B
AUM Growth
-$376M
Cap. Flow
-$1.01B
Cap. Flow %
-10.92%
Top 10 Hldgs %
39.08%
Holding
194
New
61
Increased
26
Reduced
38
Closed
60

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$295M
2
MGM icon
MGM Resorts International
MGM
+$236M
3
CCI icon
Crown Castle
CCI
+$185M
4
BABA icon
Alibaba
BABA
+$165M
5
CTRA
Coterra Energy
CTRA
+$161M

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$395M
2
OVV icon
Ovintiv
OVV
+$154M
3
VIAB
Viacom Inc. Class B
VIAB
+$150M
4
FANG icon
Diamondback Energy
FANG
+$120M
5
PNC icon
PNC Financial Services
PNC
+$112M

Sector Composition

Rank Sector Weight
1 Financials 15.88%
2 Communication Services 15.8%
3 Energy 11.19%
4 Consumer Discretionary 10.16%
5 Healthcare 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLV icon
176
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.9B
– –
-25,000
Closed -$1.86M
PXD
177
DELISTED
Pioneer Natural Resource Co.
PXD
– –
-5,300
Closed -$987K
ARAV
178
DELISTED
Aravive, Inc. Common Stock
ARAV
– –
-13,903
Closed -$1.78M
ALXN
179
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-79,700
Closed -$9.66M
PE
180
DELISTED
PARSLEY ENERGY INC
PE
– –
-3,385,800
Closed -$110M
VIAB
181
DELISTED
Viacom Inc. Class B
VIAB
– –
-3,217,006
Closed -$150M
APC
182
DELISTED
Anadarko Petroleum
APC
– –
-491,800
Closed -$30.5M
ARRY
183
DELISTED
Array Biopharma Inc
ARRY
– –
-1,983,800
Closed -$17.7M
LLL
184
DELISTED
L3 Technologies, Inc.
LLL
– –
-165,200
Closed -$27.3M
IPXL
185
DELISTED
Impax Laboratories, Inc.
IPXL
– –
-970,400
Closed -$12.3M
BIVV
186
DELISTED
Bioverativ Inc. Common Stock
BIVV
– –
-586,551
Closed -$31.9M
SYT
187
DELISTED
Syngenta Ag
SYT
– –
-35,000
Closed -$3.1M
CSC
188
PUT
DELISTED
Computer Sciences
CSC
– –
-25,000
Closed -$1.73M
CELG
189
DELISTED
Celgene Corp
CELG
– –
-213,100
Closed -$26.5M
GCVRZ
190
DELISTED
Sanofi Contingent Value Rights
GCVRZ
– –
-7,305,164
Closed -$3.29M
4 5 6 7
8

Similar funds

CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
IMRF
Illinois Municipal Retirement Fund Oak Brook, Illinois $7.86B AUM 24.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
CMTU
Capital Markets Trading (UK) London, United Kingdom $7.95B AUM 85.98% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
MT
Midwest Trust Overland Park, Kansas $8.02B AUM 23.54% 1-Year Est. Return

PointState Capital's Q2 2017 Portfolio in Review

As of Q2 2017, PointState Capital held 194 positions worth $9.21B, down 3.9% from $9.59B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

PointState Capital withdrew a net $1.01B in Q2 2017, closing 60 positions and reducing 38 holdings. Its most notable exit was Ovintiv, an estimated $154M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 11% a quarter earlier, followed by Communication Services and Energy.

Against the trend, PointState Capital opened a new position in Citigroup worth $321M.

  • PointState Capital's largest Q2 2017 buy was Citigroup: 4,804,460 shares worth $321M.
  • PointState Capital added most to Alibaba in Q2 2017, an estimated $165M increase.
  • PointState Capital's biggest Q2 2017 reduction was DuPont de Nemours, cutting an estimated $395M.
  • PointState Capital fully exited Ovintiv in Q2 2017, selling an estimated $154M.
  • PointState Capital's ten largest holdings make up 39% of its $9.21B portfolio in Q2 2017.
  • PointState Capital opened 61 new positions and closed 60 in Q2 2017.
  • PointState Capital's portfolio value fell 3.9% quarter-over-quarter to $9.21B.

Based on PointState Capital's 13F filing for Q2 2017, filed 14 Aug 2017.